Skip to main content
Premium Trial:

Request an Annual Quote

Blackstone Adds Customization to Software; Three New Hires Bring Biology Experience


When Blackstone Computing launched its PowerCloud middleware software platform in November, CEO Brian Ritchie said the company was moving away from its roots as a “technology agnostic” consulting business and toward a tools-and-platform model. But recognizing that the life sciences present a number of computational challenges that software alone can’t solve, the company announced last week that it is adding a new suite of customization services to its PowerCloud offering.

As part of this move, Blackstone has also hired three new scientific consultants for its professional services team: Glen Otero, formerly an application scientist at DoubleTwist; Richard Groves, previously head of scientific services at Genomica; and John Smutko, formerly a research investigator at Millennium Pharmaceuticals. The three replace several Blackstone scientific consultants who left the company in recent months in response to its change in direction.

Ritchie said the company’s scientific consulting staff is back up to its original size now and there are no hard feelings on either side of the departures. As Blackstone moved toward its new software-centric model, he said, “Some of our staff wanted to remain pure consultants, yet the company was moving in a different direction. We’ve brought in people that understood our new model…with experience in tools companies and the commercial services environment.”

Blackstone’s former employees, who include Matthew Trunnell, Michael Athanas, Chris Dagdigian, and William Van Etten, have moved on to independent consulting careers.

The new group at Blackstone will concentrate on three aspects of customization for PowerCloud: configuration services to adapt the technology to a company’s organizational structure; migration services to convert clients’ data analysis pipelines into the new environment; and acceleration services to optimize third-party applications.

Blackstone seems to be bucking a trend in the bioinformatics software sector to move away from shrink-wrapped software and toward customization. Is Blackstone jeopardizing its business by changing directions now? “We’re not an application company. If we were, I’d say absolutely,” said Ritchie. The risks are different for an IT infrastructure company than a scientific applications vendor, he explained. “For applications, what’s hot today may not be needed tomorrow; but for infrastructure, that glue is a company’s strategic investment and allows them to plug in applications, hardware, and so forth. It has much longer staying power.”

— BT

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.